Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 184

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Role of insulin and insulin resistance in androgen excess disorders

Open access
Unluhizarci, Kursad, Karaca, Zuleyha, Kelestimur, Fahrettin · 2021 · World Journal of Diabetes

Abstract

Insulin has complex effects on cell growth, metabolism and differentiation, and these effects are mediated by a cell-surface bound receptor and eventually a cascade of intracellular signaling events. Among the several metabolic and growth-promoting effects of insulin, insulin resistance is defined as an attenuated effect of insulin on glucose metabolism, primarily the limited export of blood glucose into skeletal muscle and adipose tissue. On the other hand, not all the signaling pathways and insulin-responsive tissues are equally affected, and some effects other than the metabolic actions of insulin are overexpressed. Ovaries and the adrenal glands are two examples of tissues remaining sensitive to insulin actions where insulin may contribute to increased androgen secretion. Polycystic ovary syndrome (PCOS) is the most common form of androgen excess disorder (AED), and its pathogenesis is closely associated with insulin resistance. Patients with idiopathic hirsutism also exhibit insulin resistance, albeit lower than patients with PCOS. Although it is not as evident as in PCOS, patients with congenital adrenal hyperplasia may have insulin resistance, which may be further exacerbated with glucocorticoid overtreatment and obesity. Among patients with severe insulin resistance syndromes, irrespective of the type of disease, hyperinsulinemia promotes ovarian androgen synthesis independently of gonadotropins. It is highly debated in whom and how insulin resistance should be diagnosed and treated among patients with AEDs, including PCOS. It is not suitable to administer an insulin sensitizer relying on only some mathematical models used for estimating insulin resistance. Instead, the treatment decision should be based on the constellation of the signs, symptoms and presence of obesity; acanthosis nigricans; and some laboratory abnormalities such as impaired glucose tolerance and impaired fasting glucose.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4239/wjd.v12.i5.616

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 56

  1. 10.1038/embor.2010.160 · DOI · Paper page
  2. 10.1007/s00125-002-0945-z · DOI
  3. 10.1101/cshperspect.a009191 · DOI · Paper page
  4. 10.1073/pnas.0901933106 · DOI · Paper page
  5. 10.1002/1873-3468.12740 · DOI · Paper page
  6. 10.2337/db06-0148 · DOI · Paper page
  7. 10.1073/pnas.0711713105 · DOI · Paper page
  8. 10.1016/j.cmet.2013.04.010 · DOI · Paper page
  9. 10.2337/dc12-0825 · DOI
  10. 10.2337/db14-0694 · DOI · Paper page
  11. 10.1210/jc.2018-00241 · DOI · Paper page
  12. 10.1159/000341822 · DOI
  13. 10.1159/000494907 · DOI
  14. 10.1002/jemt.20304 · DOI
  15. 10.1016/j.rbmo.2014.02.003 · DOI
  16. 10.1016/j.fertnstert.2011.11.036 · DOI · Paper page
  17. 10.5114/aoms.2019.82672 · DOI
  18. 10.1681/ASN.2006121410 · DOI
  19. 10.1210/jcem.84.9.6010 · DOI · Paper page
  20. 10.1016/j.jsbmb.2018.01.008 · DOI
  21. 10.2174/1381612822666160810111528 · DOI
  22. 10.1007/s43032-020-00194-7 · DOI
  23. 10.1016/j.beem.2006.03.005 · DOI · Paper page
  24. 10.1172/JCI19246 · doi:10.1172/jci19246 · Paper page
  25. 10.1111/j.1365-2265.2006.02587.x · DOI · Paper page
  26. 10.1046/j.1365-2265.1999.00786.x · DOI
  27. 10.1210/en.2003-0329 · DOI · Paper page
  28. 10.1093/humrep/15.1.21 · DOI
  29. 10.1093/oxfordjournals.humrep.a137577 · DOI
  30. 10.1530/EJE-10-0782 · DOI
  31. 10.1210/clinem/dgaa095 · DOI
  32. 10.1016/j.jpeds.2003.08.015 · DOI
  33. 10.1210/jcem.87.6.8568 · DOI
  34. 10.1210/jcem.81.3.8772557 · DOI · Paper page
  35. 10.1210/jc.2003-031626 · DOI
  36. 10.1055/s-2004-821307 · DOI
  37. 10.1155/2013/593197 · DOI
  38. 10.1159/000096434 · DOI
  39. 10.3109/09513590.2014.994598 · DOI
  40. 10.1111/ajd.12276 · DOI
  41. 10.1530/EJE-15-0460 · DOI
  42. 10.1016/j.jsbmb.2016.06.015 · DOI
  43. 10.3109/09513590903215466 · DOI
  44. 10.1159/000086363 · DOI
  45. 10.1055/a-1116-2173 · DOI
  46. 10.1530/EJE-09-0523 · DOI
  47. 10.1007/s11892-017-0829-8 · DOI
  48. 10.1016/j.jsbmb.2020.105684 · DOI
  49. 10.1056/NEJM197604012941401 · DOI · Paper page
  50. 10.1111/j.1365-2265.2005.02302.x · DOI
  51. 10.1100/tsw.2006.23 · DOI
  52. 10.1530/EDM-19-0150 · DOI
  53. 10.1111/dme.12189 · DOI
  54. 10.1038/oby.2008.336 · DOI
  55. 10.1007/978-981-15-1792-1_8 · DOI
  56. 10.1007/s00404-017-4422-9 · DOI

Cited by

See all 184

Metadata

Authors
Unluhizarci, K., Karaca, Z., & Kelestimur, F.
Venue
World Journal of Diabetes
Published
2021-05-15
Volume
12
Issue
5
Pages
616-629
ISSN
1948-9358 (ISSN-L)
OpenAlex
W3157385145
Cited by
184
References
16
FWCI
14.79
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of insulin and insulin resistance in androgen excess disorders. https://app.cochat.ai/papers/10.4239/wjd.v12.i5.616
The paper
Unluhizarci, K., Karaca, Z., & Kelestimur, F. (2021). Role of insulin and insulin resistance in androgen excess disorders. World Journal of Diabetes. https://doi.org/10.4239/wjd.v12.i5.616

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.